Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Via Munich office, Kurma launches oncology company Tacalyx

French VC’s company creation office in Munich yields first start-up, a Max Planck Institute spinout

Paul Bonanos, Associate Editor
September 27, 2019 10:26 PM UTC

Tacalyx, the first company created from French VC Kurma’s new Munich office, signals continued interest in tumor-associated carbohydrate antigens (TACAs), the targeting of sugars up-regulated in cancers.

Kurma Partners opened the German office early this year with the intention of creating start-ups based on academic research in that country, which the firm believes has been underserved by VCs (see “Kurma’s Munich Move”)...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Kurma Partners S.A.